pbmcap.com
Xalud Therapeutics - PBM Capital Group
http://www.pbmcap.com/portfolio-companies/xalud
Xalud is exploring new methods to combat pain by creating novel therapies that target activated glial cells. Xalud Therapeutics, Inc. is developing novel therapies for the treatment of neuro-inflammatory diseases. Xalud is also developing treatments for inflammatory joint disorders including osteoarthritis and rheumatoid arthritis. PBM Capital Group Invests in Xalud Therapeutics. June 25, 2015. CareFusion Signs Exclusive Distribution Agreement With Breas Medical. February 11, 2015. April 25, 2014.
info.traderszone.net
The hunt for new painkillers that will end the opioid crisis | TradersZone Newswire
http://info.traderszone.net/hunt-new-painkillers-will-end-opioid-crisis
Write For Us / Submit Content. The hunt for new painkillers that will end the opioid crisis. The hunt for new painkillers that will end the opioid crisis. The Stock Market had become an Illusion. The hunt for new painkillers that will end the opioid crisis. January 13, 2017. The hunt for new painkillers that will end the opioid crisis. In 2015. The number of deaths from heroin overdose tripled. Between 2000 and 2014, and it only seems to be growing. RELATED: Opioids affect health in a multitude of ways.